Malaria Vaccine Market
Malaria Vaccine Market Forecasts to 2030 - Global Analysis By Agent (Anopheles Species, Plasmodium Vivax, Plasmodium Falciparum and Other Agents), Vaccine Type, Route of Administration, Distribution Channel, End User and By Geography
|
Years Covered |
2021-2030 |
|
Estimated Year Value (2023) |
US $54.1 BN |
|
Projected Year Value (2030) |
US $369.5 BN |
|
CAGR (2023 - 2030) |
31.6% |
|
Regions Covered |
North America, Europe, Asia Pacific, South America, and Middle East & Africa |
|
Countries Covered |
US, Canada, Mexico, Germany, UK, Italy, France, Spain, Japan, China, India, Australia, New Zealand, South Korea, Rest of Asia Pacific, South America, Argentina, Brazil, Chile, Middle East & Africa, Saudi Arabia, UAE, Qatar, and South Africa |
|
Largest Market |
North America |
|
Highest Growing Market |
Asia Pacific |
According to Stratistics MRC, the Global Malaria Vaccine Market is accounted for $54.1 billion in 2023 and is expected to reach $369.5 billion by 2030 growing at a CAGR of 31.6% during the forecast period. Vaccines against malaria are medicines that offer protection against the infectious sickness carried by mosquitoes. The bite of a female Anopheles mosquito carrying the malaria virus transmits the disease, sometimes referred to as plasmodium infection. Sweating, fever, and chills are signs of this chronic illness. There are a few different ways to administer these vaccines: intramuscular, subcutaneous, and intradermal injections.
According to the WHO, there were around 229 million malaria infections and 409,000 fatalities worldwide in 2019. Malaria has primarily plagued tropical areas such as Africa, Asia, Central America, and South America.
Market Dynamics:
Driver:
High Incidence of malaria
Malaria has been a significant health concern for many years, particularly in tropical and subtropical regions. Several factors contribute to the prevalence of malaria, including climate change, drug resistance in mosquitoes and parasites, inadequate healthcare infrastructure, and socioeconomic factors. However, the rise in prevalence occurs due to changing environmental conditions or shifts in the effectiveness of existing prevention strategies. These factors contribute to the growth of the market.
Restraint:
Lack of healthcare infrastructure
People find it challenging to obtain vaccines due to restricted access to healthcare facilities resulting from inadequate infrastructure for healthcare. There aren't any clinics or hospitals in remote locations that are set up to properly store and give immunizations. Inadequate healthcare systems may also result in restricted availability of health education and immunization awareness initiatives. Low vaccination uptake and vaccine hesitancy may result from this lack of knowledge. This is the element impeding the market's expansion.
Opportunity:
Increase in the number of research and development activities
Developments in vaccination cost, safety, and effectiveness have an impact on market expansion. Public and commercial research investments have an impact on the availability of more recent and potent vaccinations. Furthermore, particularly in environments with limited resources, government and international health agency support can have a major influence on the uptake and dissemination of malaria vaccinations. These are the variables affecting the market's expansion.
Threat:
High cost of medication development
The process of developing a vaccine necessitates significant financial investments due to the rigorous research, clinical trials, and regulatory procedures involved. The sustainability of mass production and distribution is impacted if the cost of manufacturing is high. Long-term efforts to get the vaccination to people who need it most could be hampered by it. Pharmaceutical firms, governments, and organizations that sponsor these initiatives have difficulties because to the exorbitant expenses.
Covid-19 Impact:
The manufacture and delivery of medical goods, especially those required for the prevention and treatment of malaria, were hampered by the worldwide interruptions in supply chains brought about by COVID-19. This impacted the supply of diagnostic instruments, antimalarial medications, and bed nets sprayed with insecticide. Lockdowns, travel bans, and limits on face-to-face encounters all caused interruptions to clinical studies for malaria vaccinations. As a result, there has been a delay in testing, findings analysis, and gaining regulatory permissions.
The anopheles species segment is expected to be the largest during the forecast period
The anopheles species segment is expected to be the largest during the forecast period. The transmission of malaria is directly addressed by vaccination against the anopheles species. It may considerably slow the transmission of malaria by lessening the mosquito's capacity to disseminate the infection. Research on vaccinations against the malaria parasite itself is ongoing, however these efforts would be aided by the development of a vaccine against the anopheles species.
The intramuscular segment is expected to have the highest CAGR during the forecast period
The intramuscular segment is expected to have the highest CAGR during the forecast period. For medical experts, administering a vaccination intramuscularly is a rather simple process. Specialized training beyond normal injection procedures is not needed. When injected intramuscularly, certain vaccinations are more stable and maintain their effectiveness more effectively. This is particularly important for vaccinations against illnesses that are common in areas without easy access to refrigeration or healthcare services.
Region with largest share:
North America is projected to hold the largest market share during the forecast period. Due of the disease's extensive effects, efforts have been made globally to develop and implement malaria vaccinations. Because of the decreased risk within the continent, the focus in this region has mostly been on preventive methods for visitors to malaria-prone regions rather than universal immunization. The key tactics for people visiting areas where malaria is endemic continue to be preventing mosquito bites and using antimalarial drugs.
Region with highest CAGR:
Asia Pacific is projected to hold the highest CAGR over the forecast period due to the increasing number of malarial infections, rising population and increasing government initiative for disease control. To create more potent malaria vaccines, academic institutions, pharmaceutical firms, and international health organizations have been working nonstop. In an effort to increase effectiveness, some ongoing research focuses on alternate vaccination strategies that target various phases of the malaria parasite's lifecycle.
Key players in the market
Some of the key players in Malaria Vaccine market include Taj Pharmaceuticals Limited, Sanofi, Actiza Pharmaceutical Private Limited, Ipca Laboratories Ltd., Sumaya Biotech, Hikma Pharmaceuticals PLC, Bliss GVS Pharma Ltd., Amneal Pharmaceuticals LLC, Strides Pharma Science Limited, VLP Therapeutics, Novartis AG, Pfizer Inc., Mylan N.V., Zydus Cadila, Cipla Inc., Sun Pharmaceutical Industries Ltd., Ipca Laboratories Ltd. and GeoVax.
Key Developments:
In February 2023, Sun Pharmaceutical Industries Ltd., one of India's leading pharmaceutical companies, has announced the acquisition of a 26.09% stake in Agatsa Software Pvt. Ltd. and a 27.39% stake in Remidio Innovative Solutions Pvt. Ltd., both of which are digital health startups.
In November 2022, Novartis and Medicines for Malaria Venture (MMV) have announced plans to advance a ganaplacide/lumefantrine- solid dispersion formulation (SDF) into a Phase III clinical trial to treat individuals with acute uncomplicated malaria caused by Plasmodium falciparum.
Agents Covered:
• Anopheles Species
• Plasmodium Vivax
• Plasmodium Falciparum
• Other Agents
Vaccine Types Covered:
• Pre-Erythrocytic Vaccine
• Erythrocytic Vaccine
• Multi-antigen Vaccine
• Other Vaccine Types
Route of Administrations Covered:
• Intramuscular
• Subcutaneous
• Intradermal
Distribution Channels Covered:
• Retail Pharmacy
• Online Pharmacy
• Hospital Pharmacy
• Other Distribution Channels
End Users Covered:
• Hospitals
• Specialty Clinics
• Homecare
• Other End Users
Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
Table of Contents
1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Malaria Vaccine Market, By Agent
5.1 Introduction
5.2 Anopheles Species
5.3 Plasmodium Vivax
5.4 Plasmodium Falciparum
5.5 Other Agents
6 Global Malaria Vaccine Market, By Vaccine Type
6.1 Introduction
6.2 Pre-Erythrocytic Vaccine
6.3 Erythrocytic Vaccine
6.4 Multi-antigen Vaccine
6.5 Other Vaccine Types
7 Global Malaria Vaccine Market, By Route of Administration
7.1 Introduction
7.2 Intramuscular
7.3 Subcutaneous
7.4 Intradermal
8 Global Malaria Vaccine Market, By Distribution Channel
8.1 Introduction
8.2 Retail Pharmacy
8.3 Online Pharmacy
8.4 Hospital Pharmacy
8.5 Other Distribution Channels
9 Global Malaria Vaccine Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Specialty Clinics
9.4 Homecare
9.5 Other End Users
10 Global Malaria Vaccine Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 New Zealand
10.4.6 South Korea
10.4.7 Rest of Asia Pacific
10.5 South America
10.5.1 Argentina
10.5.2 Brazil
10.5.3 Chile
10.5.4 Rest of South America
10.6 Middle East & Africa
10.6.1 Saudi Arabia
10.6.2 UAE
10.6.3 Qatar
10.6.4 South Africa
10.6.5 Rest of Middle East & Africa
11 Key Developments
11.1 Agreements, Partnerships, Collaborations and Joint Ventures
11.2 Acquisitions & Mergers
11.3 New Product Launch
11.4 Expansions
11.5 Other Key Strategies
12 Company Profiling
12.1 Taj Pharmaceuticals Limited
12.2 Sanofi
12.3 Actiza Pharmaceutical Private Limited
12.4 Ipca Laboratories Ltd.
12.5 Sumaya Biotech
12.6 Hikma Pharmaceuticals PLC
12.7 Bliss GVS Pharma Ltd.
12.8 Amneal Pharmaceuticals LLC
12.9 Strides Pharma Science Limited
12.10 VLP Therapeutics
12.11 Novartis AG
12.12 Pfizer Inc.
12.13 Mylan N.V.
12.14 Zydus Cadila
12.15 Cipla Inc.
12.16 Sun Pharmaceutical Industries Ltd.
12.17 Ipca Laboratories Ltd.
12.18 GeoVax
List of Tables
1 Global Malaria Vaccine Market Outlook, By Region (2021-2030) ($MN)
2 Global Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
3 Global Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
4 Global Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
5 Global Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
6 Global Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
7 Global Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
8 Global Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
9 Global Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
10 Global Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
11 Global Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
12 Global Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
12 Global Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
14 Global Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
15 Global Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
16 Global Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
17 Global Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
18 Global Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
19 Global Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
20 Global Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
21 Global Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
22 Global Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
23 Global Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
24 Global Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
25 Global Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
26 North America Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
27 North America Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
28 North America Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
29 North America Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
30 North America Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
31 North America Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
32 North America Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
33 North America Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
34 North America Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
35 North America Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
36 North America Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
37 North America Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
38 North America Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
39 North America Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
40 North America Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
41 North America Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
42 North America Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
43 North America Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
44 North America Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
45 North America Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
46 North America Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
47 North America Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
48 North America Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
49 North America Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
50 North America Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
51 Europe Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
52 Europe Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
53 Europe Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
54 Europe Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
55 Europe Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
56 Europe Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
57 Europe Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
58 Europe Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
59 Europe Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
60 Europe Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
61 Europe Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
62 Europe Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
63 Europe Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
64 Europe Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
65 Europe Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
66 Europe Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
67 Europe Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
68 Europe Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
69 Europe Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
70 Europe Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
71 Europe Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
72 Europe Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
73 Europe Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
74 Europe Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
75 Europe Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
76 Asia Pacific Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
77 Asia Pacific Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
78 Asia Pacific Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
79 Asia Pacific Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
80 Asia Pacific Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
81 Asia Pacific Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
82 Asia Pacific Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
83 Asia Pacific Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
84 Asia Pacific Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
85 Asia Pacific Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
86 Asia Pacific Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
87 Asia Pacific Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
88 Asia Pacific Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
89 Asia Pacific Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
90 Asia Pacific Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
91 Asia Pacific Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
92 Asia Pacific Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
93 Asia Pacific Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
94 Asia Pacific Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
95 Asia Pacific Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
96 Asia Pacific Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
97 Asia Pacific Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
98 Asia Pacific Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
99 Asia Pacific Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
100 Asia Pacific Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
101 South America Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
102 South America Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
103 South America Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
104 South America Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
105 South America Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
106 South America Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
107 South America Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
108 South America Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
109 South America Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
110 South America Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
111 South America Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
112 South America Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
113 South America Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
114 South America Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
115 South America Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
116 South America Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
117 South America Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
118 South America Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
119 South America Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
120 South America Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
121 South America Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
122 South America Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
123 South America Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
124 South America Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
125 South America Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
126 Middle East & Africa Malaria Vaccine Market Outlook, By Country (2021-2030) ($MN)
127 Middle East & Africa Malaria Vaccine Market Outlook, By Agent (2021-2030) ($MN)
128 Middle East & Africa Malaria Vaccine Market Outlook, By Anopheles Species (2021-2030) ($MN)
129 Middle East & Africa Malaria Vaccine Market Outlook, By Plasmodium Vivax (2021-2030) ($MN)
130 Middle East & Africa Malaria Vaccine Market Outlook, By Plasmodium Falciparum (2021-2030) ($MN)
131 Middle East & Africa Malaria Vaccine Market Outlook, By Other Agents (2021-2030) ($MN)
132 Middle East & Africa Malaria Vaccine Market Outlook, By Vaccine Type (2021-2030) ($MN)
133 Middle East & Africa Malaria Vaccine Market Outlook, By Pre-Erythrocytic Vaccine (2021-2030) ($MN)
134 Middle East & Africa Malaria Vaccine Market Outlook, By Erythrocytic Vaccine (2021-2030) ($MN)
135 Middle East & Africa Malaria Vaccine Market Outlook, By Multi-antigen Vaccine (2021-2030) ($MN)
136 Middle East & Africa Malaria Vaccine Market Outlook, By Other Vaccine Types (2021-2030) ($MN)
137 Middle East & Africa Malaria Vaccine Market Outlook, By Route of Administration (2021-2030) ($MN)
138 Middle East & Africa Malaria Vaccine Market Outlook, By Intramuscular (2021-2030) ($MN)
139 Middle East & Africa Malaria Vaccine Market Outlook, By Subcutaneous (2021-2030) ($MN)
140 Middle East & Africa Malaria Vaccine Market Outlook, By Intradermal (2021-2030) ($MN)
141 Middle East & Africa Malaria Vaccine Market Outlook, By Distribution Channel (2021-2030) ($MN)
142 Middle East & Africa Malaria Vaccine Market Outlook, By Retail Pharmacy (2021-2030) ($MN)
143 Middle East & Africa Malaria Vaccine Market Outlook, By Online Pharmacy (2021-2030) ($MN)
144 Middle East & Africa Malaria Vaccine Market Outlook, By Hospital Pharmacy (2021-2030) ($MN)
145 Middle East & Africa Malaria Vaccine Market Outlook, By Other Distribution Channels (2021-2030) ($MN)
146 Middle East & Africa Malaria Vaccine Market Outlook, By End User (2021-2030) ($MN)
147 Middle East & Africa Malaria Vaccine Market Outlook, By Hospitals (2021-2030) ($MN)
148 Middle East & Africa Malaria Vaccine Market Outlook, By Specialty Clinics (2021-2030) ($MN)
149 Middle East & Africa Malaria Vaccine Market Outlook, By Homecare (2021-2030) ($MN)
150 Middle East & Africa Malaria Vaccine Market Outlook, By Other End Users (2021-2030) ($MN)
List of Figures
RESEARCH METHODOLOGY
We at ‘Stratistics’ opt for an extensive research approach which involves data mining, data validation, and data analysis. The various research sources include in-house repository, secondary research, competitor’s sources, social media research, client internal data, and primary research.
Our team of analysts prefers the most reliable and authenticated data sources in order to perform the comprehensive literature search. With access to most of the authenticated data bases our team highly considers the best mix of information through various sources to obtain extensive and accurate analysis.
Each report takes an average time of a month and a team of 4 industry analysts. The time may vary depending on the scope and data availability of the desired market report. The various parameters used in the market assessment are standardized in order to enhance the data accuracy.
Data Mining
The data is collected from several authenticated, reliable, paid and unpaid sources and is filtered depending on the scope & objective of the research. Our reports repository acts as an added advantage in this procedure. Data gathering from the raw material suppliers, distributors and the manufacturers is performed on a regular basis, this helps in the comprehensive understanding of the products value chain. Apart from the above mentioned sources the data is also collected from the industry consultants to ensure the objective of the study is in the right direction.
Market trends such as technological advancements, regulatory affairs, market dynamics (Drivers, Restraints, Opportunities and Challenges) are obtained from scientific journals, market related national & international associations and organizations.
Data Analysis
From the data that is collected depending on the scope & objective of the research the data is subjected for the analysis. The critical steps that we follow for the data analysis include:
- Product Lifecycle Analysis
- Competitor analysis
- Risk analysis
- Porters Analysis
- PESTEL Analysis
- SWOT Analysis
The data engineering is performed by the core industry experts considering both the Marketing Mix Modeling and the Demand Forecasting. The marketing mix modeling makes use of multiple-regression techniques to predict the optimal mix of marketing variables. Regression factor is based on a number of variables and how they relate to an outcome such as sales or profits.
Data Validation
The data validation is performed by the exhaustive primary research from the expert interviews. This includes telephonic interviews, focus groups, face to face interviews, and questionnaires to validate our research from all aspects. The industry experts we approach come from the leading firms, involved in the supply chain ranging from the suppliers, distributors to the manufacturers and consumers so as to ensure an unbiased analysis.
We are in touch with more than 15,000 industry experts with the right mix of consultants, CEO's, presidents, vice presidents, managers, experts from both supply side and demand side, executives and so on.
The data validation involves the primary research from the industry experts belonging to:
- Leading Companies
- Suppliers & Distributors
- Manufacturers
- Consumers
- Industry/Strategic Consultants
Apart from the data validation the primary research also helps in performing the fill gap research, i.e. providing solutions for the unmet needs of the research which helps in enhancing the reports quality.
For more details about research methodology, kindly write to us at info@strategymrc.com
Frequently Asked Questions
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: info@strategymrc.com or phone: +1-301-202-5929
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
We have 3 different licensing options available in electronic format.
- Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
- 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
- Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment.
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards.
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.
Request Customization
We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at info@strategymrc.com or call us on +1-301-202-5929.
Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.
WHY CHOOSE US ?
Assured Quality
Best in class reports with high standard of research integrity
24X7 Research Support
Continuous support to ensure the best customer experience.
Free Customization
Adding more values to your product of interest.
Safe & Secure Access
Providing a secured environment for all online transactions.
Trusted by 600+ Brands
Serving the most reputed brands across the world.
